STRATA CRITICAL MEDICAL, INC. (SRTA)

Import this data to Google Sheets with:

=jivedata("SRTA","financials")

Full statements spill as a table. For one cell: =jivedata("SRTA","Revenue") or =jivedata("SRTA","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

STRATA CRITICAL MEDICAL, INC.

SRTA • CIK 0001779128

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$225,180	$248,693	$197,141	$211,924
Cost of Revenue	$183,058	$189,774	$156,015	$171,181
Gross Profit	—	—	$41,126	$54,398
Operating Income (Loss)	$-68,117	$-33,926	$-22,353	$-18,198
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-57,542	$-27,562	$-20,066	$-20,948
Income Tax Expense (Benefit)	$-1,466	$-255	$0	$-4
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent	—	—	$-20,066	$-23,159
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent	—	—	$61,413	$63,380
Net Income (Loss) Attributable to Parent	$-56,076	$-27,307	$41,347	$40,221
Selling, General and Administrative Expense	—	—	$60,875	$64,854
Amortization of Intangible Assets	$6,036	$2,986	$2,604	$9,953
Operating Expenses	$-33,226	—	$63,479	$74,807
Interest Income (Expense), Nonoperating, Net	—	$7,214	$4,241	$2,569
Fair Value Adjustment of Warrants	$-2,125	$850	$-4,278	$-2,979
Gain (Loss) on Sale of Investments	$8	$0	$-5,195	$-5,195
Nonoperating Income (Expense)	$10,575	$6,364	$2,287	$-2,750
Weighted Average Number of Shares Outstanding, Basic	73,524,476	77,499,423	82,092,345	87,264,759
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	26,643,700	28,577,270	28,526,135	15,915,902

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash Equivalents, at Carrying Value	—	—	$30,968	$16,317
Restricted Cash and Cash Equivalents, Current	$1,148	$1,269	$264	$264
Accounts Receivable, after Allowance for Credit Loss, Current	$21,005	$21,591	$39,958	$43,407
Assets	$294,938	$256,675	$325,472	$332,698
Debt Securities, Available-for-sale, Current	$138,264	$108,757	$30,263	$6,436
Prepaid Expense and Other Assets, Current	$17,971	$10,747	$24,739	$54,586
Disposal Group, Including Discontinued Operation, Assets, Current	—	—	$0	$0
Assets, Current	$206,261	$160,742	$126,192	$121,010
Property, Plant and Equipment, Net	$2,899	$30,918	$36,444	$40,704
Intangible Assets, Net (Excluding Goodwill)	$20,519	$13,653	$47,502	$60,008
Goodwill	$40,373	$41,050	$88,210	$106,946
Liabilities	$60,638	$34,737	$46,400	$53,380
Operating Lease, Right-of-Use Asset	$23,484	$8,876	$3,107	$3,940
Other Assets, Noncurrent	$1,402	$1,436	$24,017	$90
Accounts Payable and Accrued Liabilities, Current	$23,859	$12,766	$19,142	$18,381
Operating Lease, Liability, Current	$4,787	$3,304	$652	$1,054
Liabilities, Current	$35,491	$22,726	$19,794	$45,779
Warrants and Rights Outstanding	$4,958	$5,808	$1,530	$0
Operating Lease, Liability, Noncurrent	$19,738	$6,018	$2,655	$3,201
Deferred Income Tax Liabilities, Net	$451	$185	$348	$271
Other Liabilities, Noncurrent	—	—	$22,073	$4,129
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$7	$7	$7	$7
Additional Paid in Capital	$390,083	$407,076	$424,616	$433,224
Accumulated Other Comprehensive Income (Loss), Net of Tax	$3,964	$1,753	$0	$0
Retained Earnings (Accumulated Deficit)	$-159,754	$-186,898	$-145,551	$-153,913
Stockholders' Equity Attributable to Parent	$234,300	$221,938	$279,072	$279,318
Accounts Receivable, Allowance for Credit Loss	$98	$112	$1,066	$1,058
Preferred Stock, Shares Authorized	2,000,000	2,000,000	2,000,000	2,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	400,000,000	400,000,000	400,000,000	400,000,000
Common Stock, Shares, Issued	75,131,425	79,419,028	86,702,183	88,466,806

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-56,076	$-27,307	$41,347	$40,221
Net Cash Provided by (Used in) Operating Activities	$-32,349	$-2,519	$-48,914	$-36,032
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$-66	$-80	$-339	$-616
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-15,402	$-9,374	$11,585	$-43,737
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$29,021	$19,647	$31,232	$54,531
Gain (Loss) on Disposition of Business	—	—	$56,996	$56,652
Payments to Acquire Businesses, Net of Cash Acquired	$0	$2,230	$66,535	$101,358
Depreciation, Depletion and Amortization	$7,111	$5,962	$8,185	$16,287
Share-based Payment Arrangement, Noncash Expense	$12,501	$19,893	$17,832	$17,007
Payments to Acquire Intangible Assets	—	$2,119	$1,415	$1,070
Fair Value Adjustment of Warrants	$-2,125	$850	$-4,278	$-2,979
Payments to Acquire Property, Plant, and Equipment	$2,109	$30,875	$9,595	$12,346
Payments to Acquire Held-to-maturity Securities	$265,835	$143,255	$146,258	$56,109
Proceeds from Sale and Maturity of Held-to-maturity Securities	$264,537	$177,450	$226,200	$105,400
Proceeds from Sale of Debt Securities, Available-for-sale	$20,532	$0	$70,163	$70,163
Net Cash Provided by (Used in) Investing Activities	$17,089	$-1,016	$69,750	$1,511
Impairment of Intangible Assets, Finite-lived	—	—	$0	$0
Tangible Asset Impairment Charges	—	—	$1,673	$1,673
Gain (Loss) on Sale of Investments	$8	$0	$-5,195	$-5,195
Foreign Currency Transaction Gain (Loss), Realized	—	—	$798	$798
Accretion (Amortization) of Discounts and Premiums, Investments	$6,519	$3,990	$2,214	$1,152
Deferred Income Tax Expense (Benefit)	$-1,466	$-255	$432	$332
Other Operating Activities, Cash Flow Statement	—	$-12	$471	$554
Proceeds from Stock Options Exercised	$70	$168	$193	$174
Payment, Tax Withholding, Share-based Payment Arrangement	$146	$5,683	$9,105	$8,436
Payments for Repurchase of Common Stock	—	$244	$0	$0
Net Cash Provided by (Used in) Financing Activities	$-76	$-5,759	$-8,912	$-8,600
Cash and Cash Equivalents, at Carrying Value	$27,873	$18,378	$30,968	$54,861
Restricted Cash and Cash Equivalents	$1,148	$1,269	$264	$-330
Increase (Decrease) in Prepaid Expense and Other Assets	$6,032	$-6,352	$1,686	$230
Increase (Decrease) in Accounts Receivable	$10,254	$998	$12,034	$5,774
Increase (Decrease) in Other Noncurrent Assets	$-4	$70	$-666	$-669
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$9,049	$-8,338	$2,378	$-1,181
Increase (Decrease) in Contract with Customer, Liability	$117	$-119	$1,684	$-623
Income Taxes Paid, Net	$16	$0	$87	$157
Other Significant Noncash Transaction, Value of Consideration Received	—	—	$75,357	$75,357
Stock Issued	—	—	$8,414	$12,681
Capital Expenditures Incurred but Not yet Paid	—	$375	$128	$-47
Other Significant Noncash Transaction, Value of Consideration Given	—	$3,022	$0	$0

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("SRTA","financials")

Full statements spill as a table. For one cell: =jivedata("SRTA","Revenue") or =jivedata("SRTA","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.